Sanofi, GSK get nod for late stage trial of Covid-19 vaccine in India Ruchika Sharma9 July 2021 1:21 PM ISTNew Delhi: Sanofi SA and GlaxoSmithKline Plc have received an approval from Indian authorities for a late-stage clinical trial of their...
GSK proposal for marketing Belimumab rejected by CDSCO panel Medical Dialogues Team8 July 2021 6:31 PM ISTNew Delhi: In a major setback to GlaxoSmithKline (GSK) Pharmaceuticals, the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
GSK, Alector enter USD 2.2 billion deal for Parkinson's, Alzheimer's drugs Ruchika Sharma5 July 2021 11:00 AM ISTUK: GlaxoSmithKline Plc and U.S. firm Alector Inc will together develop antibody-based treatments for Parkinson's, Alzheimer's and other similar...
GSK, Sanofi COVID vaccine Phase 2 trial shows strong immune responses across all adult age groups Ruchika Sharma18 May 2021 10:00 AM ISTParis: The Sanofi and GSK adjuvanted recombinant COVID-19 vaccine candidate achieved strong rates of neutralizing antibody responses, in line with...
GSK cancer drug JEMPERLI gets speedy USFDA approval Ruchika Sharma25 April 2021 9:30 AM ISTLondon: GlaxoSmithKline plc has recently announced that the US Food and Drug Administration (USFDA) has approved JEMPERLI (dostarlimab-gxly), a...
GSK to sell Vemgal plant to Hetero Labs for Rs 180 crore Ruchika Sharma2 April 2021 12:14 PM ISTNew Delhi: Drug firm GlaxoSmithKline Pharmaceuticals on Wednesday said its board has approved the sale of its manufacturing facility located at Vemgal...
GSK gets EMA panel recommendation to approve Benlysta for adult patients with active lupus nephritis Ruchika Sharma29 March 2021 9:30 AM ISTUK: GlaxoSmithKline plc (GSK) has recently announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...
GSK, Vir Biotechnology submit EUA request to USFDA for VIR-7831 for early Covid-19 treatment Ruchika Sharma28 March 2021 10:30 AM ISTLondon and San Francisco: GlaxoSmithKline plc and Vir Biotechnology, Inc. have recently announced the submission of an application to the U.S. Food...
GSK, Vir Biotechnology to halt enrollment in US COVID-19 antibody trial sub-study Ruchika Sharma4 March 2021 3:50 PM ISTNew Delhi: Vir Biotechnology and Britain's GSK said on Wednesday they would pause enrollment into a study testing their experimental COVID-19 antibody...
Sanofi, GSK begin Phase 2 study of protein-based COVID-19 vaccine Ruchika Sharma23 Feb 2021 12:03 PM ISTParis and London: Sanofi and GSK have recently announced the initiation of a new Phase 2 study with 720 volunteers aged 18 and over to select the most...
GSK, Vir Biotechnology expand coronavirus collaboration to include new therapies including influenza Ruchika Sharma20 Feb 2021 9:30 AM ISTLondon: GlaxoSmithKline plc and Vir Biotechnology, Inc. have recently announced they have signed a binding agreement to expand their existing...
Bharat Biotech, GSK, PATH enter into product transfer agreement for malaria vaccine Ruchika Sharma28 Jan 2021 4:52 PM ISTNew Delhi: GSK, PATH, and Bharat Biotech (BBIL) have recently announced the signing of a product transfer agreement for the malaria vaccine,...
